Analysts’ New Coverage for May 26th (AVLN, COAG, MKKGY, OGS, PS, PSN, RGS, SPTX, SR, VRCA)

Analysts’ new coverage for Tuesday, May 26th:

Evercore Inc started coverage on shares of Avalyn Pharma (NASDAQ:AVLN). They issued an outperform rating and a $51.00 price target on the stock.

Wedbush began coverage on shares of Hemab Therapeutics (NASDAQ:COAG). They issued an outperform rating and a $42.00 target price on the stock.

Evercore Inc initiated coverage on shares of Hemab Therapeutics (NASDAQ:COAG). They issued an outperform rating and a $50.00 price target on the stock.

Jefferies Financial Group Inc. started coverage on shares of Merck KGaA (OTCMKTS:MKKGY). The firm issued a hold rating on the stock.

Wolfe Research started coverage on shares of ONE Gas (NYSE:OGS). The firm issued a peer perform rating on the stock.

Bank of America Corporation began coverage on shares of Pershing Square (NYSE:PS). They issued a neutral rating and a $42.00 target price on the stock.

Oppenheimer Holdings, Inc. assumed coverage on shares of Pershing Square (NYSE:PS). Oppenheimer Holdings, Inc. issued a market perform rating on the stock.

BNP Paribas Exane began coverage on shares of Parsons (NYSE:PSN). They issued an underperform rating on the stock.

Lake Street Capital initiated coverage on shares of Regis (NASDAQ:RGS). The firm issued a buy rating and a $42.00 target price on the stock.

Leerink Partners assumed coverage on shares of Seaport Therapeutics (NASDAQ:SPTX). Leerink Partners issued an outperform rating and a $35.00 price target on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Seaport Therapeutics (NASDAQ:SPTX). JPMorgan Chase & Co. issued an overweight rating and a $42.00 price target on the stock.

Wolfe Research began coverage on shares of Spire (NYSE:SR). They issued a peer perform rating on the stock.

HC Wainwright initiated coverage on shares of Verrica Pharmaceuticals (NASDAQ:VRCA). HC Wainwright issued a buy rating and a $12.00 price target on the stock.

Receive News & Ratings for Avalyn Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalyn Pharma Inc and related companies with MarketBeat.com's FREE daily email newsletter.